Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$358M |
| 2 |
VanEck Gold Miners ETF
GDX
|
+$284M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$280M |
| 4 |
NXP Semiconductors
NXPI
|
+$268M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$216M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.61B |
| 2 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$407M |
| 3 |
STJ
St Jude Medical
STJ
|
+$368M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
+$330M |
| 5 |
Apple
AAPL
|
+$302M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 4.53% |
| 2 | Energy | 3.9% |
| 3 | Technology | 3.29% |
| 4 | Healthcare | 2.41% |
| 5 | Industrials | 2.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3851
HCI Group
HCI
$2.23B
| $463K | ﹤0.01% |
10,157
-10,244
| -50% | -$450K |
|
3852
CALL
Pitney Bowes
PBI
$2.4B
| $463K | ﹤0.01% |
35,300
-12,800
| -27% | -$181K |
|
3853
Invesco Large Cap Growth ETF
PWB
$2.29B
| $463K | ﹤0.01% |
13,492
-545
| -4% | -$18.3K |
|
|
RDUS
3854
PUT
DELISTED
Radius Recycling
RDUS
| $463K | ﹤0.01% |
22,400
-32,900
| -59% | -$769K |
|
|
SRDX
3855
DELISTED
Surmodics
SRDX
| $463K | ﹤0.01% |
19,240
-11,071
| -37% | -$271K |
|
|
MLNX
3856
DELISTED
Mellanox Technologies, Ltd.
MLNX
| $461K | ﹤0.01% |
9,054
-62,031
| -87% | -$2.95M |
|
3857
iShares Core S&P Total US Stock Market ETF
ITOT
$94.3B
| $460K | ﹤0.01% |
8,510
+400
| +5% | +$21.3K |
|
|
FGL
3858
DELISTED
Fidelity & Guaranty Life
FGL
| $460K | ﹤0.01% |
16,560
-82,615
| -83% | -$2.13M |
|
3859
Barings BDC
BBDC
$864M
| $459K | ﹤0.01% |
24,048
+5,695
| +31% | +$109K |
|
3860
CALL
Masco
MAS
$14.1B
| $459K | ﹤0.01% |
13,500
-86,300
| -86% | -$2.88M |
|
|
HTD
3861
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$913M
| $457K | ﹤0.01% |
18,565
-9,742
| -34% | -$237K |
|
3862
PUT
Sanofi
SNY
$103B
| $457K | ﹤0.01% |
10,100
+2,000
| +25% | +$84.8K |
|
3863
Trimble
TRMB
$13.2B
| $457K | ﹤0.01% |
14,280
-15,028
| -51% | -$465K |
|
3864
Vanda Pharmaceuticals
VNDA
$307M
| $456K | ﹤0.01% |
32,500
-106,287
| -77% | -$1.51M |
|
|
VGR
3865
DELISTED
Vector Group Ltd.
VGR
| $455K | ﹤0.01% |
35,689
-83,274
| -70% | -$1.12M |
|
|
FFG
3866
DELISTED
FBL Financial Group
FFG
| $455K | ﹤0.01% |
6,947
-6,329
| -48% | -$439K |
|
3867
Acadia Healthcare
ACHC
$2.76B
| $454K | ﹤0.01% |
10,431
+2,982
| +40% | +$121K |
|
3868
CALL
iShares MSCI Hong Kong ETF
EWH
$1.24B
| $454K | ﹤0.01% |
20,400
-106,000
| -84% | -$2.26M |
|
3869
PUT
Puma Biotechnology
PBYI
$404M
| $454K | ﹤0.01% |
12,200
-10,100
| -45% | -$369K |
|
|
SINA
3870
CALL
DELISTED
Sina Corp
SINA
| $454K | ﹤0.01% |
6,300
-71,100
| -92% | -$5.03M |
|
|
CHY
3871
Calamos Convertible and High Income Fund
CHY
$1.01B
| $452K | ﹤0.01% |
39,642
-15,892
| -29% | -$177K |
|
3872
PUT
First Majestic Silver
AG
$7.41B
| $451K | ﹤0.01% |
55,800
-50,900
| -48% | -$454K |
|
3873
ATI
ATI
$25.6B
| $451K | ﹤0.01% |
25,133
-122,214
| -83% | -$2.3M |
|
3874
Liquidity Services
LQDT
$1.22B
| $451K | ﹤0.01% |
56,396
-4,107
| -7% | -$36K |
|
3875
Bio-Techne
TECH
$11.2B
| $451K | ﹤0.01% |
17,756
-972
| -5% | -$25.1K |
|
Similar funds
Citigroup's Q1 2017 Portfolio in Review
As of Q1 2017, Citigroup held 7,587 positions worth $112B, up 1.1% from $111B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Citigroup withdrew a net $4.67B in Q1 2017, closing 298 positions and reducing 4,171 holdings. Its most notable exit was St Jude Medical, an estimated $368M position sold in full.
By sector, the portfolio is most concentrated in Financials at 4.5% of assets, down from 5% a quarter earlier, followed by Energy and Technology.
Against the trend, Citigroup opened a new position in Kayne Anderson Acquisition Corp. Unit worth $25.1M.
- Citigroup's largest Q1 2017 buy was Kayne Anderson Acquisition Corp. Unit: 2,500,000 shares worth $25.1M.
- Citigroup added most to Walt Disney in Q1 2017, an estimated $358M increase.
- Citigroup's biggest Q1 2017 reduction was iShares Russell 2000 ETF, cutting an estimated $1.61B.
- Citigroup fully exited St Jude Medical in Q1 2017, selling an estimated $368M.
- Citigroup's ten largest holdings make up 33% of its $112B portfolio in Q1 2017.
- Citigroup opened 332 new positions and closed 298 in Q1 2017.
- Citigroup's portfolio value rose 1.1% quarter-over-quarter to $112B.
Based on Citigroup's 13F filing for Q1 2017, filed 12 May 2017.